Extended surgical adjuvant thiotepa for mammary carcinoma.
D000230:Adenocarcinoma / Q000628:therapy*; D001772:Blood Cell Count; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008207:Lymphatic Metastasis; D008408:Mastectomy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D011182:Postoperative Care; D011446:Prospective Studies; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use*
D013852:Thiotepa